Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
3
×
new york top stories
san francisco top stories
3
×
boston blog main
boston top stories
fda
national
new york blog main
roche
san diego blog main
san diego top stories
san francisco blog main
allergan
billy dunn
biogen
biotech
blueprint medicines
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
clinical data
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
drug prices
drug pricing
drugs
entrectinib
europe top stories
evrysdi
express scripts
foundation medicine
gene therapy
genentech
genfit
What
approved
3
×
drug
medicine
new
3
×
fda
atrophy
cancer
daily
data
deeper
disease
dna
evrysdi
fatty
fingerprint
friday
genetic
going
green
home
horizon
intended
intercept
known
lights
liquid
liver
marketed
matter
muscular
nash
nd
nonalcoholic
oks
oral
patients
risdiplam
roche
second
spinal
Language
unset
Current search:
approved
×
new
×
" national top stories "
×
" san francisco top stories "
×
@xconomy.com
4 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues